Team

We are led by globally recognised scientists in the field of age-related disease with more than 1000 scientific publications and an award-winning AI team with more than 30 global A.I awards.

MANAGEMENT TEAM

Wade Smith

Wade Smith

CHAIRMAN AND CEO

16 years of emerging markets and entrepreneur direct private investment experience in Russia and China. He has built, invested, and sold multiple technology and internet businesses in both of these markets.

Bimal Shah

Bimal Shah

COO

Extensive experience from start-ups to multi­nationals, enabling digital solutions, business transformation and bringing existing companies into the digital world by creating new solutions with technology.

Hamish Badenoch

Hamish Badenoch

DIRECTOR & CFO

Qualified as a chartered accountant and spent 3 years at Deloitte in London. Clients included a number of private and listed UK, US and other international businesses in the fields of technology, insurance, investment management and private equity.

Zhangming Niu

Zhangming Niu

CTO

Recognised leader in AI development with 10 years of experience in building novel products for blue chip Companies, governments and institutions. He is ranked in the top 10 of multiple global AI competitions for healthcare and industry applications.

Paul Sitoh

Paul Sitoh

HEAD OF BLOCKCHAIN TECHNOLOGY

Over 10 years of development experience from mobile to backend systems. Paul has led the delivery of two Hyperledger Fabric based projects for the finance industry and is at the forefront of Blockchain technology.

SCIENTIFIC AND MEDICAL ADVISORY BOARD

Chief Scientific Adviser

Prof. David Rubinstein

Prof. David Rubinstein

David Rubinsztein is the Professor of Molecular Neurogenetics and a UK Dementia Research Institute Professor at the University of Cambridge. He is Deputy Director of the Cambridge Institute for Medical Research. Rubinsztein was elected Fellow of the Academy of Medical Sciences (2004), EMBO member (2011) and Fellow of the Royal Society (2017). He was awarded the Graham Bull Prize (2007), Thudichum Medal (2017), Roger de Spoelberch prize (2017) and the Goudie Medal (2020).

Medical Advisory Board

Prof. Jon Storm-Mathisen

Prof. Jon Storm-Mathisen

Neuroscientist, Royal Norwegian Academy of Sciences, Fellow of the Norwegian Academy of Science and Letters, Senior Professor of Medicine at the University of Oslo School of Medicine.

Prof. Henrik Schirmer

Prof. Henrik Schirmer

Professor in cardiovascular epidemiology at the University of Oslo.

Prof. Geir Selbæk

Prof. Geir Selbæk

The research director at the Norwegian National Advisory and professor at the Faculty of Medicine, University of Oslo.

Prof. Linda Hildegard Bergersen

Prof. Linda Hildegard Bergersen

Dean of Research and Researcher Training, University of Oslo. Professor of Physiology at the University of Oslo and professor of Aging Neurobiology at the University of Copenhagen. Fellow of the Norwegian Academy of Science and Letters.

Prof. Hilde Loge Nilsen

Prof. Hilde Loge Nilsen

Professor at the Department of Clinical Molecular Biology in University of Oslo. Head of DNA-repair group in Akershus University Hospital. Fellow of the Norwegian Academy of Science and Letters.

Prof. Evandro Fang

Prof. Evandro Fang

Associate professor and group leader at the University of Oslo.

Dr Guang Yang

Dr Guang Yang

Honorary research fellow at NHLI, Imperial College London and an imaging physicist at Royal Brompton Hospital.

ALADDIN HEALTHCARE TECHNOLOGIES SE

BOARD OF DIRECTORS


WADE MENPES-SMITH

CHAIRMAN & MANAGING DIRECTOR

BIMAL SHAH

DEPUTY CHAIRMAN

ALEXANDER BADENOCH

MEMBER

IMPRINT

Aladdin Healthcare Technologies SE
Unter den Linden 10
10117 Berlin

Berlin MD: Wade Menpes-Smith
Board Chairman: Wade Menpes-Smith
Commercial Register: Berlin, HRB 173762

Seat of the company: Berlin